SYNERGO
Synergo is a medical devices manufacturer that specializes in cancer treatment devices.
SYNERGO
Industry:
Health Care Manufacturing Medical Medical Device Oncology
Founded:
1998-01-01
Address:
Amstelveen, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.synergo-medical.com
Total Employee:
11+
Status:
Active
Contact:
+31 20 642 3719
Email Addresses:
[email protected]
Similar Organizations
Albino Dias de Andrade
ADA is a medical manufacturer that supplies gauze and non-woven compresses, adult incontinence products, and bandages.
Aries
Aries designs and develops disposable and medical devices for infusion, transfusion, nutrition, and oncology.
ExoProTher Medical
ExoProTher Medical is a biomedical startup that specializes in nano-particles cancer treatment.
Grupo IMO
Grupo IMO is an integrated network of healthcare centers specialized in cancer treatments using the latest irradiation techniques.
Hoya Surgical Optics
Hoya is a medical device manufacturer specializing in cataract care.
Medica
Medica is a medical device company that specialises in designing and manufacturing a wide range of medical devices.
Oncotherm
OncoTherm is a medical device company that develops, manufactures and markets cancer treatment devices.
Smart Matrix
Smart Matrix is a medical device manufacturing company that specializes in wound care, regenerative medicine, and medical devices.
Official Site Inspections
http://www.synergo-medical.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Synergo"
COMPANY PROFILE | MEDICAL ENTERPRISES
Medical Enterprises Group is a growing and dynamic medical device company. The company's leading product, Synergo RITE, offers an advanced treatment modality for patients suffering from non muscle invasive bladder cancer. ...See details»
PHYSICIAN INFO | Synergo RF Thermo-chemotherapy
Multinational RCT Synergo® Vs. BCG : Synergo 78.1% disease-free at 2-year follow-up vs. 64.8 [Arends et al., Eur Urol. 2016]. In 2001, a multicenter RCT demonstrates the efficacy of Synergo® and its superiority over mitomycin โฆSee details»
Synergo - Crunchbase Company Profile & Funding
Organization. Synergo . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Also Known As Synergo Medical; Legal Name Medical Enterprises Europe B.V; Company Type For Profit; โฆSee details»
Synergo - Crunchbase Company Profile & Funding
Synergo develops and provides a radiofrequency induced thermo-chemotherapy for the treatment of invasive cancer. Synergo focuses on minimally-invasive therapies providing benefits for patients and healthcare systems. Synergo's technology is based on homogenous RF radiation โฆSee details»
Optimizing intravesical mitomycin C therapy in non-muscle โฆ
Mar 11, 2014 A computerized chemohyperthermia administration system has been commercialized as Synergo ® (Medical ... results of 2 European Organization for Research and Treatment of Cancer randomized trials ...See details»
Synergo - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Synergo . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Synergo has 1 current employee profile, CEO and Co-Founder Avigdor Lev. Contacts. Edit Contacts Section. We're โฆSee details»
Synergie Medicale BRG Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Synergie Medicale BRG Inc of Longueuil, QC. Get the latest business insights from Dun & Bradstreet.See details»
Synergo for non-muscle-invasive bladder cancer - NICE
Medical technology guidance scope Synergo for non-muscle-invasive bladder cancer 1 Technology 1.1 Description of the technology Synergo uses radiofrequency-induced thermo-chemotherapeutic effect (RITE) to improve how chemotherapy is given to treat non-muscle โฆSee details»
Synergo | Powerful tri-modality of Radiofrequency, Chemotherapy โฆ
Synergo® is an advanced, minimally invasive technology for the treatment of non-muscle invasive bladder cancer (NMIBC). ... Since then the treatment has become available in many leading medical centres. So far, thousands of patients have been treated with Synergo® worldwide โฆSee details»
Synergie Medicale Brg Inc. Company Profile - Dun & Bradstreet
Synergie Medicale Brg Inc. Company Profile | Toronto, ON, Canada | Competitors, Financials & Contacts - Dun & BradstreetSee details»
Synergo for non-muscle-invasive bladder cancer | Guidance - NICE
Nov 30, 2021 NICE medical technologies guidance addresses specific technologies notified to NICE by companies. The โcase for adoptionโ is based on the claimed advantages of introducing the specific technology compared with current management of the condition. ... This guidance โฆSee details»
Synergy Medical Corporation Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Synergy Medical Corporation of Arcadia, CA. Get the latest business insights from Dun & Bradstreet.See details»
Efficacy and safety of a new device for intravesical ... - Springer
May 31, 2015 Purpose We report for the first time the activity and safety of Unithermia® (Elmedical Ltd, Hod-Hasharon, Israel), a novel device for administration of MMC-C with hyperthermia (HT), that employs conductive heating, in a series of non-grade 3 non-muscle โฆSee details»
CBI Health Acquires Groupe Synergo | CBI Health
Saint-Jean-sur-Richelieu, Quebec โ CBI Health is pleased to announce that Marie-Claude Leduc and the Groupe Synergo team have joined our growing Canadian network. Since 1996, Groupe Synergo has delivered care with a specialty focus in physical rehabilitation and return to work โฆSee details»
Understanding Bladder Cancer Treatments - SYNERGO RITE
This above is not a substitute for professional medical advice and is to support and not to substitute the discussion between you and your doctor. While clinical studies support the safety and effectiveness of the Synergo System when used in the treatment of non-muscle invasive โฆSee details»
Clinique Privée à Québec | Synergo Solutions Santé
Synergo Solutions Santé à Québec. Description. À l'aide de notre réseau médecins experts et notre réseau de cliniques médicales, nous sommes en mesure de vous offrir un rendez-vous rapide pour une expertise médicale dans toutes les régions du Québec et dans les principales โฆSee details»
Organizational synergy in medical groups - PubMed
Synergy in medical groups works best where there is: A clearly stated mission and vision statement, as well as specific goals and objectives; careful selection of associates; a small group of between seven and nine members; a short-term duration of ten years or less; and a certain โฆSee details»
SYNERGO RF | ÜBER UNS | MEDICAL ENTERPRISES
Das führende Produkt des Unternehmens, Synergo®, bietet eine neue Behandlungsform für Patienten, die an oberflächlichem Blasenkarzinom leiden. top of page. COMING SOON. HOME. Die Technologie. Systembeschreibung; Wirkungsmechanismus; Publikationen. Publikationen โฆSee details»
Organization flies Palestinian child to Cleveland for medical help
15 hours ago Itโs an organization that provides critical support for children with severe injuries and amputations who cannot receive adequate treatment in Gaza. Heal Palestine was established in January 2024.See details»
SYNERGO PUBLICATIONS | Microwave (RF)-Induced โฆ
SYNERGO RITE published peer-reviewed clinical and scientific articles for the treatment of non muscle invasive bladder cancer, bcg unresponsive and CIS patients. ... mitomycin C combined with local microwavehyperthermia in nonโmuscleโinvasive bladder cancer with increased โฆSee details»